Font Size: a A A

Research On Innovation Effect Of Accelerated Depreciation Policy Applied To Z Biomedical Enterprises

Posted on:2023-09-04Degree:MasterType:Thesis
Country:ChinaCandidate:S R WangFull Text:PDF
GTID:2569307097491744Subject:Tax
Abstract/Summary:PDF Full Text Request
As a sub-industry of strategic emerging industry,the development of biomedical industry is of great significance to people’s health and national scientific and technological innovation.As innovation activities are characterized by high investment,externality and high risk,and the biomedical industry is also characterized by high technology and long cycle,it is necessary for the government to guide r&d activities.Although China issued a perfect notice in 2014 to allow six industries to implement accelerated depreciation tax preference,and since then,the scope has been continuously expanded and the content has been enriched,but there are still some problems when biomedical enterprises enjoy this preference.Therefore,it is still of certain value to analyze how to use accelerated depreciation tax policy to promote the innovation and development of biomedical enterprises.This paper adopts literature analysis method and case analysis method to study the influence of accelerated depreciation tax preference on innovation of biomedical enterprises.Firstly,related research literature is sorted out,related concepts and analysis indicators are introduced,accelerated depreciation policies related to biomedical enterprises are summarized,and the industry background is summarized.Then combined with the analysis of enterprise financial data,it is concluded that Z enterprise has increased the cost of business accounting by enjoying this tax preference,reduced the tax base,reduced the tax burden in the early stage,reduced the capital pressure and invested more in research and development,which promoted the innovation and development of Z enterprise.However,in the process of enjoying policies,Z enterprises have problems such as inadequate use of policies,increased cost accounting workload and tax-related risks,and increased tax burden in the later period.The feasible suggestions put forward in this paper are as follows: improve the management accounting level,reasonably determine the depreciation life,make full use of the existing policies,reasonably match other tax incentives;Strengthen exchanges and cooperation with medical colleges and research institutions,and strengthen supervision of research and development projects.
Keywords/Search Tags:Accelerated depreciation, Research and development innovation, Biomedical enterprise
PDF Full Text Request
Related items